A conversation with CIRM board member Yael Wyte

Written by Holly Alyssa MacCormick Yael Wyte knows all too well how difficult it can be to have or care for someone with Alzheimer’s Disease—she has been working with and advocating for people with Alzheimer's Disease for more than 20 years. Earlier this year, Wyte joined the board of the California Institute for Regenerative Medicine … Continue reading A conversation with CIRM board member Yael Wyte

How California is advancing our understanding of Alzheimer’s disease using stem cells 

Over 14,000 people in Fresno County are living with Alzheimer's, and it’s estimated that more than 720,000 people are living with the brain disorder in California.   That’s why the California Institute for Regenerative Medicine (CIRM)—a state of California agency dedicated to funding regenerative medicine research—joined the Alzheimer's Association Walk to End Alzheimer’s in Fresno/Madera to … Continue reading How California is advancing our understanding of Alzheimer’s disease using stem cells 

Two common viruses could trigger Alzheimer’s disease

Researchers from Tufts University and the University of Oxford have found that two common viruses —the varicella zoster and herpes simplex viruses— could trigger Alzheimer's disease. Varicella zoster (VZV) is an extremely common virus causes which causes chickenpox. Once cured of the first infection, the virus tends to linger in peripheral nerves where they remain dormant. When these dormant viruses are … Continue reading Two common viruses could trigger Alzheimer’s disease

Study reveals new evidence of key mechanism in Alzheimer’s

In California, 690,000 people aged 65 and older are living with Alzheimer’s, a degenerative brain disease and the most common form of dementia. In the United States, 5.8 million people aged 65 and older live with Alzheimer's disease. Alzheimer's affects memory, thinking and behavior and symptoms eventually grow in severity to interfere with daily tasks.   … Continue reading Study reveals new evidence of key mechanism in Alzheimer’s

Replacement brain cells offer hope for Parkinson’s treatment

A colony of iPSCs from a Parkinson's patient (left) and dopaminergic neurons made from these iPSCs (right) to model PD. (Image credit: Jeanne Loring) A new study that used adult blood stem cells to create replacement brain nerve cells appears to help rats with Parkinson’s. In Parkinson’s, the disease attacks brain nerve cells that produce … Continue reading Replacement brain cells offer hope for Parkinson’s treatment

How some brilliant research may have uncovered a potential therapy for Alzheimer’s 

Dr. Nicole Koutsodendris, photo courtesy Gladstone Institutes In the world of scientific research, the people doing clinical trials tend to suck up all the oxygen in the room. They’re the stars, the ones who are bringing potential therapies to patients. However, there’s another group of researchers who toil away in the background, but who are … Continue reading How some brilliant research may have uncovered a potential therapy for Alzheimer’s 

Raising awareness about mental health

THIS BLOG IS ALSO AVAILABLE AS AN AUDIOCAST ON SPOTIFY World Mental Health Day is observed on 10 October every year. It's a time to try and raise awareness about mental health issues and the impact they have not just on the individual but their family, their community and all of us. The theme for … Continue reading Raising awareness about mental health

Lack of diversity impacts research into Alzheimer’s and dementia

THIS BLOT IS ALSO AVAILABLE AS AN AUDIOCAST ON SPOTIFY A National Institutes of Allergy and Infectious Diseases clinical trial admissions coordinator collects information from a volunteer to create a medical record. Credit: NIAID Alzheimer’s research has been in the news a lot lately, and not for the right reasons. The controversial decision by the … Continue reading Lack of diversity impacts research into Alzheimer’s and dementia

Paving the way for a treatment for dementia

What happens in a stroke When someone has a stroke, the blood flow to the brain is blocked. This kills some nerve cells and injures others. The damaged nerve cells are unable to communicate with other cells, which often results in people having impaired speech or movement. While ischemic and hemorrhagic strokes affect large blood … Continue reading Paving the way for a treatment for dementia

Hollywood and Patient Advocacy – two people who are on our Board but never boring

At first glance, Lauren Miller Rogen and David Higgins, PhD, seem an unlikely pair. She’s an actor, writer, and director and has worked with some of the biggest names in Hollywood. He has a doctorate in molecular biology and genetics and has worked at some of the most well-known companies in biotech. But together they … Continue reading Hollywood and Patient Advocacy – two people who are on our Board but never boring